Dissemin is shutting down on January 1st, 2025

Published in

Elsevier, The Lancet Neurology, 9(18), p. 845-856, 2019

DOI: 10.1016/s1474-4422(19)30137-1

Links

Tools

Export citation

Search in Google Scholar

Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial

Journal article published in 2019 by Diego Cadavid, Michelle Mellion, Raymond Hupperts, Keith R. Edwards, Peter A. Calabresi, Jelena Drulović, Gavin Giovannoni, Hans-Peter Hartung, Douglas L. Arnold, Elizabeth Fisher, Richard Rudick, Sha Mi, Yi Chai, Jie Li, Yiwei Zhang and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO